Thyroid dysgenesis and the dysplasia hypothesis in tuberous sclerosis

American Journal of Medical Genetics

Volumn 47, Issue 3, 1993, Pages 417-419

  Bereket, A ^a   Wilson, T A ^a  

^a STONY BROOK UNIVERSITY   (United States)

Author keywords

hamartia; hypothyroidism; thyroid; thyroid dysgenesis; tuberous sclerosis

Indexed keywords

LEVOTHYROXINE;

ARTICLE; AUTOSOMAL DOMINANT INHERITANCE; CASE REPORT; CONGENITAL HYPOTHYROIDISM; FEMALE; HAMARTOMA; HUMAN; INFANT; ORGANOGENESIS; PHENOTYPE; PRIORITY JOURNAL; THYROID ADENOMA; THYROID FUNCTION; TUBEROUS SCLEROSIS;

EID: 0027244034     PISSN: 01487299     EISSN: None     Source Type: Journal    
DOI: 10.1002/ajmg.1320470324     Document Type: Article

References (8)

1. Brett EM (1991): Neurocutaneous syndromes. In Brett EM (ed): “ Paediatric Neurology.” New York: Churchill Livingstone, pp 571–576.
2. Gomez MR (1990): The tuberous sclerosis complex phenotypes. In Ishibashi Y, Hori Y (eds): “ Tuberous Sclerosis and Neurofibromatosis: Epidemiology, Pathophysiology, Biology and Management.” New York: Excerpta Medica, pp 199–210.
3. Gomez MR, Kuntz N (1988): Pathogenesis. In Gomez MR (ed): “ Tuberous Sclerosis.” New York: Raven Press, pp 245–249.
4. Ilgren EB, Westmoreland D (1984): Tuberous sclerosis: Unusual associations in four cases. J Clin Pathol 37: 272–278.
5. Kousseff BG (1990): The phakomatoses as paracrine growth disorders (paracrinopathies). Clin Genet 37: 97–105.
6. Kousseff BG (1992): Hypothesis: Jadassohn nevus phakomatosis: A paracrinopathy with variable phenotype. Am J Med Genet 43: 651–661.
7. Sareen CK, Ruvalcaba RHA, Scotould MJ, Mahoney CP, Kelley VC (1972): Tuberous sclerosis, clinical, endocrine and metabolic studies. Am J Dis Child 123: 34–39.
8. Zimmerman D (1988): The Endocrine System. In Gomez MR (ed): “ Tuberous Sclerosis.” New York: Raven Press, pp 169–176.